Work

150P Interim results of the multicenter phase II study on induction pembrolizumab plus chemotherapy followed by radiotherapy in locally advanced head and neck cancer

Year: 2024

Type: article

Abstract: Conclusions: Toripalimab combined with chemotherapy is effective and well tolerated as first line treatment for patients with advanced thymic carcinoma.Clinical trial identification: ChiCTR2000039155.

Source: Immuno-Oncology Technology

DOI: 10.1016/j.iotech.2024.100779

Authors: T. Antonova, I. Pokataev, M. Nosova, O. Stativko, E. Kuzmina, M.A. Lyadova, E. Sabitov, S. Kravtsov, E. Tsareva, A. Fedorova, K. Lisitsyna, M. Dolov, A. Tedeeva, D. Stroyakovskiy, L. Zhukova, P. Feoktistova, S. Iugai, R. Sydykova, G. Alizade, V.N. Galkin

Institutions: Moscow City Oncology Hospital №62, Moscow Clinical Scientific Center, Mercy Medical Center

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,170

OpenAlex ID: W4405375165

FWCI:

Cites:

Cited by:

Related to: 10